Effects of covid-19 on the central nervous system forms of damage to the central
nervous system in cases of COVID-19 virus
disease. Particular attention
The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017, as shown in the Global Burden of
Diseases (GBD) Study 2016. Unpacking how this burden varies regionally
Covid-19 in a patient with anca-associated systemic vasculitis, receiving anti-b cell therapy (rituximab) nervous system. Clinical outcome of COVID-19 was favorable, with no signs of respiratory failure, and CRP
Psychiatric face of COVID-19 cardio-respiratory manifestations, affects the function of the central
nervous system (CNS). The severe